KZR•benzinga•
Kezar Life Sciences Q4 2024 GAAP EPS $(2.77) Beats $(2.88) Estimate, Cash $132M
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 25, 2025 by benzinga